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Difficulty in the identification and differentiation of clinically relevant Ochrobactrum species
The genus Ochrobactrum currently comprises nine species, Ochrobactrum anthropi (Holmes et al., 1988) , Ochrobactrum intermedium (Velasco et al., 1998) , Ochrobactrum lupini (Trujillo et al., 2005) , Ochrobactrum tritici and Ochrobactrum grignonense , Ochrobactrum gallinifaecis (Kämpfer et al., 2003) , Ochrobactrum oryzae (Tripathi et al., 2006) , Ochrobactrum pseudintermedium (Teyssier et al., 2007) and Ochrobactrum cytisi (Zurdo-Piñeiro et al., 2007) . Only three species, O. anthropi, O. intermedium and O. pseudintermedium, have been reported to occur in clinical material (Alnor et al., 1994; Appelbaum & Campbell, 1980; Barson et al., 1987; Braun et al., 1996; Brivet et al., 1993; Cieslak et al., 1992 Cieslak et al., , 1996 Earhart et al., 1997; Greven & Nelson, 2001; Inoue et al., 1999; Jelveh & Cunha, 1999; Kettaneh et al., 2003; Mahmood et al., 2000; Perez-Blanco et al., 2005; Romero-Gomez et al., 2004; Vaidya et al., 2006; Wheen et al., 2002; Teyssier et al., 2007) . O. anthropi was described by Holmes et al. (1988) to accommodate oxidase-positive, Gram-negative, non-fermentative bacilli previously known as 'Achromobacter group Vd', occasionally infecting humans. Today O. anthropi is recognized as an emerging pathogen of low virulence, predominantly isolated from immunocompromised patients, but there are also 19 cases of it being isolated from immunocompetent hosts (Vaidya et al., 2006) . Only two cases of O. intermedium infection have been reported. In 1999, O. intermedium was isolated from blood and a liver abscess in a patient after liver transplantation (Möller et al., 1999) , and in 2005, a presumptive systemic O. intermedium infection in a patient with bladder cancer was reported (Apisarnthanarak et al., 2005) . Recently a novel species, O. pseudintermedium, was described that was isolated from patients hospitalized in intensive-care units (Teyssier et al., 2007) . The differentiation of Ochrobactrum species by physiological tests is quite difficult, because of their high phenotypic similarity (Table 1) . O. anthropi is often the only Ochrobactrum species present in the databases of commercially available identification systems (including the API 20NE kit) (Teyssier et al., 2005a) and as a consequence O. intermedium may be misidentified as O. anthropi as occurred in a recently published case report describing O. anthropi as the causative agent of a pelvic abscess in an immunocompetent host (Vaidya et al., 2006) . The initial identification of that isolate (RMA 16449) as O. anthropi (Vaidya et al., 2006) was performed with the API 20E kit (bioMérieux) and by partial 16S rRNA gene sequencing. Strain RMA 16449 was later included in comparative analysis to study the genetic diversity among 112 Ochrobactrum strains by applying a polyphasic approach using extended 16S rRNA gene analysis, recA gene sequencing, fatty acid analysis and DNA-DNA hybridization studies. Of the 16S rRNA gene, 1390 bp were sequenced as described by Kämpfer et al. (2003) . In the BLASTN search using the sequence information from the entire 1390 bp fragment (GenBank accession no. AM409326), the highest similarity of 100 % was indeed detected with 'O. anthropi' strain CCUG 39736 (GenBank accession no. AM114408). However, to add to the confusion, this reference strain, initially identified as O. intermedium-specific sequence motifs as described by Scholz et al. (2006) . Vaidya et al. (2006) identified 'O. anthropi' using biochemical testing and partial sequencing of the 16S rRNA gene that we clearly identified in this study as O. intermedium using extended 16S rRNA and recA gene analysis as well as DNA-DNAhybridization studies, emphasizing the need for additional molecular typing approaches in order to correctly identify O. anthropi and O. intermedium.
In this context, recA analysis was shown to serve (Scholz et al., 2006) as a suitable tool for differentiating O. anthropi, O. intermedium and Brucella species. We therefore recommend recA gene analysis for accurate typing of these organisms. RecA can also be used to correctly identify O. pseudintermedium (H. C. Scholz, personal communication), which was recently isolated from clinical specimens.
In addition to molecular typing, colistin (polymyxin E) and polymyxin B are recommended for differentiating between O. anthropi and O. intermedium in routine diagnosis (Velasco et al., 1998; Teyssier et al., 2005a) , whereby O. anthropi is sensitive and O. intermedium is resistant to both antibiotics. However, in a screening assay, 5 out of 65 confirmed O. anthropi strains were resistant and 3 out of 17 tested O. intermedium strains were sensitive to both antibiotics (H. C. Scholz, personal communication) .
In summary, commercially available test systems used in routine diagnosis are not suitable for species discrimination within the genus Ochrobactrum. We therefore recommend molecular typing Scholz et al., 2006; Teyssier et al., 2003a Teyssier et al., , b, 2005a in addition to physiological testing for a precise species identification.
Besides sequencing of the 16S rRNA gene, analysis of recA (Scholz et al., 2006) Susceptibility to: Colistin, polymyxin + 2 2 Assimilation of:
SucroseDd, D-trehalose + 2 2 Maltitol + 2 2 trans-AconitateD 2 (+) 2 *pNP, para-nitrophenyl; pNA, para-nitroanilide. DTest (based on a different method) was also performed by Holmes et al. (1988) with O. anthropi and gave congruent results. dTest (based on a different method) was also performed by Velasco et al. (1998) with O. intermedium and gave congruent results.
Correspondence
